Two patients with complete defects in interferon gamma receptor-dependent signaling - PubMed (original) (raw)
Case Reports
doi: 10.1007/s10875-007-9097-8. Epub 2007 May 21.
Affiliations
- PMID: 17514500
- DOI: 10.1007/s10875-007-9097-8
Free article
Case Reports
Two patients with complete defects in interferon gamma receptor-dependent signaling
Jeroen G Noordzij et al. J Clin Immunol. 2007 Sep.
Free article
Abstract
Unusual susceptibility to mycobacterial infections can be caused by deleterious mutations in genes that encode the interferon-gamma receptor 1 chain. Such mutations hamper the activation of macrophages by a type 1 immune response and result in enhanced survival of intracellular pathogens. We here report two patients with unusual mycobacterial infections, both diagnosed with homozygous deleterious interferon-gamma receptor 1 gene mutations. Patient 1 became ill after Bacillus Calmette-Guérin vaccination at the age of 9 months and died at the age of 18 months. She carried a homozygous C71Y mutation in the extracellular part of the mature interferon-gamma receptor 1 protein, resulting in the lack of detectable protein expression and absence of interferon-gamma dependent signaling. Patient 2 became ill at the age of 3 years, is still alive at 19 years of age, and has suffered from five successive infection episodes with atypical mycobacteria. A homozygous splice-site mutation in intron 3 was identified, resulting in the deletion of exon 3 at the mRNA level and consequently a truncated interferon-gamma receptor 1 protein with absence of the transmembrane domain. Protein expression and interferon-gamma dependent signaling were not detectable.
Similar articles
- Severe disseminated mycobacterial infection in a boy with a novel mutation leading to IFN-γR2 deficiency.
Kilic SS, van Wengen A, de Paus RA, Celebi S, Meziane B, Hafizoglu D, van Dissel JT, van de Vosse E. Kilic SS, et al. J Infect. 2012 Dec;65(6):568-72. doi: 10.1016/j.jinf.2012.08.008. Epub 2012 Aug 15. J Infect. 2012. PMID: 22902943 - Impaired interferon gamma-mediated immunity and susceptibility to mycobacterial infection in childhood.
Remus N, Reichenbach J, Picard C, Rietschel C, Wood P, Lammas D, Kumararatne DS, Casanova JL. Remus N, et al. Pediatr Res. 2001 Jul;50(1):8-13. doi: 10.1203/00006450-200107000-00005. Pediatr Res. 2001. PMID: 11420412 Review. - Evaluation of interleukin-12 receptor β1 and interferon gamma receptor 1 deficiency in patients with disseminated BCG infection.
Pourakbari B, Hosseinpour Sadeghi R, Mahmoudi S, Parvaneh N, Keshavarz Valian S, Mamishi S. Pourakbari B, et al. Allergol Immunopathol (Madr). 2019 Jan-Feb;47(1):38-42. doi: 10.1016/j.aller.2018.06.005. Epub 2018 Sep 27. Allergol Immunopathol (Madr). 2019. PMID: 30268380 - In a novel form of IFN-gamma receptor 1 deficiency, cell surface receptors fail to bind IFN-gamma.
Jouanguy E, Dupuis S, Pallier A, Döffinger R, Fondanèche MC, Fieschi C, Lamhamedi-Cherradi S, Altare F, Emile JF, Lutz P, Bordigoni P, Cokugras H, Akcakaya N, Landman-Parker J, Donnadieu J, Camcioglu Y, Casanova JL. Jouanguy E, et al. J Clin Invest. 2000 May;105(10):1429-36. doi: 10.1172/JCI9166. J Clin Invest. 2000. PMID: 10811850 Free PMC article. - IFN-γR1 defects: Mutation update and description of the IFNGR1 variation database.
van de Vosse E, van Dissel JT. van de Vosse E, et al. Hum Mutat. 2017 Oct;38(10):1286-1296. doi: 10.1002/humu.23302. Epub 2017 Aug 3. Hum Mutat. 2017. PMID: 28744922 Review.
Cited by
- Laboratory evaluation of the IFN-γ circuit for the molecular diagnosis of Mendelian susceptibility to mycobacterial disease.
Esteve-Solé A, Sologuren I, Martínez-Saavedra MT, Deyà-Martínez À, Oleaga-Quintas C, Martinez-Barricarte R, Martin-Nalda A, Juan M, Casanova JL, Rodriguez-Gallego C, Alsina L, Bustamante J. Esteve-Solé A, et al. Crit Rev Clin Lab Sci. 2018 May;55(3):184-204. doi: 10.1080/10408363.2018.1444580. Epub 2018 Mar 4. Crit Rev Clin Lab Sci. 2018. PMID: 29502462 Free PMC article. Review. - Molecular immunity to mycobacteria: knowledge from the mutation and phenotype spectrum analysis of Mendelian susceptibility to mycobacterial diseases.
Qu HQ, Fisher-Hoch SP, McCormick JB. Qu HQ, et al. Int J Infect Dis. 2011 May;15(5):e305-13. doi: 10.1016/j.ijid.2011.01.004. Epub 2011 Feb 16. Int J Infect Dis. 2011. PMID: 21330176 Free PMC article. Review. - Deletion of the entire interferon-γ receptor 1 gene causing complete deficiency in three related patients.
de Vor IC, van der Meulen PM, Bekker V, Verhard EM, Breuning MH, Harnisch E, van Tol MJ, Wieringa JW, van de Vosse E, Bredius RG. de Vor IC, et al. J Clin Immunol. 2016 Apr;36(3):195-203. doi: 10.1007/s10875-016-0244-y. Epub 2016 Mar 1. J Clin Immunol. 2016. PMID: 26931784 Free PMC article. - A novel form of cell type-specific partial IFN-gammaR1 deficiency caused by a germ line mutation of the IFNGR1 initiation codon.
Kong XF, Vogt G, Chapgier A, Lamaze C, Bustamante J, Prando C, Fortin A, Puel A, Feinberg J, Zhang XX, Gonnord P, Pihkala-Saarinen UM, Arola M, Moilanen P, Abel L, Korppi M, Boisson-Dupuis S, Casanova JL. Kong XF, et al. Hum Mol Genet. 2010 Feb 1;19(3):434-44. doi: 10.1093/hmg/ddp507. Epub 2009 Oct 31. Hum Mol Genet. 2010. PMID: 19880857 Free PMC article. - Human Lentiviral Gene Therapy Restores the Cellular Phenotype of Autosomal Recessive Complete IFN-γR1 Deficiency.
Hahn K, Pollmann L, Nowak J, Nguyen AHH, Haake K, Neehus AL, Waqas SFH, Pessler F, Baumann U, Hetzel M, Casanova JL, Schulz A, Bustamante J, Ackermann M, Lachmann N. Hahn K, et al. Mol Ther Methods Clin Dev. 2020 Apr 11;17:785-795. doi: 10.1016/j.omtm.2020.04.002. eCollection 2020 Jun 12. Mol Ther Methods Clin Dev. 2020. PMID: 32355867 Free PMC article.
References
- Leukemia. 1999 Dec;13(12):1901-28 - PubMed
- Exp Hematol. 1999 Sep;27(9):1368-74 - PubMed
- Clin Immunol. 2002 Jan;102(1):25-7 - PubMed
- J Clin Invest. 1997 Dec 1;100(11):2658-64 - PubMed
- Science. 1993 Mar 19;259(5102):1739-42 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials